11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Metabolic Activity on [18F]-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography and Glucose Transporter-1 Expression Might Predict Clinical Outcomes in Patients With Limited Disease Small-Cell Lung Cancer Who Receive Concurrent Chemoradiation

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Limited disease small-cell lung cancer responds well to concurrent chemoradiation therapy (CCRT), but shows high relapse rate and short RFS. We aimed to evaluate tumor metabolic activities measured using FDG-PET as a prognostic factor and analyze its relationships with markers of tumor biologic behavior.

          Related collections

          Author and article information

          Journal
          Clinical Lung Cancer
          Clinical Lung Cancer
          Elsevier BV
          15257304
          March 2014
          March 2014
          : 15
          : 2
          : e13-e21
          Article
          10.1016/j.cllc.2013.09.005
          24368212
          907b01bd-912b-4b95-813f-6c8d395bbed6
          © 2014

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article